Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Journal of Endocrinological Investigation
|
August 4, 2005
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age
A Colao, S Spiezia, C Di Somma, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 16, 2006
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance
Rosario Pivonello, Maurizio Galderisi, Renata S Auriemma, et al.
Frontiers in Endocrinology
|
December 17, 2021
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
Rosa Pirchio, Renata S Auriemma, Domenico Solari, et al.
Eye (London, England)
|
April 9, 2015
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression
G Cennamo, R S Auriemma, D Cardone, et al.
Journal of Endocrinological Investigation
|
September 11, 2023
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs
G Corica, R Pirchio, A Milioto, et al.
European Journal of Endocrinology
|
April 2, 2010
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission
Renata S Auriemma, Mariano Galdiero, Maria C De Martino, et al.
Neuroendocrinology
|
December 21, 2013
Effect of cabergoline on metabolism in prolactinomas
Renata S Auriemma, Luciana Granieri, Mariano Galdiero, et al.
Journal of Endocrinological Investigation
|
May 3, 2011
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia
V M Cambuli, M Galdiero, M Mastinu, et al.
European Journal of Endocrinology
|
February 25, 2006
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance
Annamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
Journal of Endocrinological Investigation
|
February 6, 2014
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status
Rosario Pivonello, Maria Cristina De Martino, Renata S Auriemma, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Journal of Endocrinological Investigation
|
August 4, 2005
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age
A Colao, S Spiezia, C Di Somma, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 16, 2006
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance
Rosario Pivonello, Maurizio Galderisi, Renata S Auriemma, et al.
Frontiers in Endocrinology
|
December 17, 2021
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
Rosa Pirchio, Renata S Auriemma, Domenico Solari, et al.
Eye (London, England)
|
April 9, 2015
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression
G Cennamo, R S Auriemma, D Cardone, et al.
Journal of Endocrinological Investigation
|
September 11, 2023
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs
G Corica, R Pirchio, A Milioto, et al.
European Journal of Endocrinology
|
April 2, 2010
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission
Renata S Auriemma, Mariano Galdiero, Maria C De Martino, et al.
Neuroendocrinology
|
December 21, 2013
Effect of cabergoline on metabolism in prolactinomas
Renata S Auriemma, Luciana Granieri, Mariano Galdiero, et al.
Journal of Endocrinological Investigation
|
May 3, 2011
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia
V M Cambuli, M Galdiero, M Mastinu, et al.
European Journal of Endocrinology
|
February 25, 2006
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance
Annamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
Journal of Endocrinological Investigation
|
February 6, 2014
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status
Rosario Pivonello, Maria Cristina De Martino, Renata S Auriemma, et al.
Page
of 9